Literature DB >> 3316030

Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid.

G Teti1, F Tomasello, M S Chiofalo, G Orefici, P Mastroeni.   

Abstract

We have investigated the role of lipoteichoic acid in mediating the adherence of different serotypes of group B streptococci to human adult and neonatal epithelial cells. Pretreatment of neonatal buccal and vaginal epithelial cells with lipoteichoic acid, but not with deacylated lipoteichoic acid, induced a marked inhibition in the adherence of all strains tested. Pretreatment of bacteria with substances known to bind lipoteichoic acid, such as monoclonal and polyclonal antipolyglycerophosphate antibodies and albumin, also resulted in adherence inhibition. Group B streptococci adhered in 6- to 10-fold-higher numbers to buccal epithelial cells from neonates older than 3 days than to those from neonates less than 1 day old. This increase in receptiveness for group B streptococci was paralleled by an increased ability of epithelial cells from older neonates to bind group B streptococcal lipoteichoic acid. These data suggest a role for the lipid portion of lipoteichoic acid in the adherence of different serotypes of group B streptococci to vaginal and neonatal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316030      PMCID: PMC260028          DOI: 10.1128/iai.55.12.3057-3064.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Binding of type-III group-B streptococci to buccal epithelial cells.

Authors:  J Bagg; I R Poxton; D M Weir; P W Ross
Journal:  J Med Microbiol       Date:  1982-08       Impact factor: 2.472

2.  Factors influencing adherence of group B streptococci to human vaginal epithelial cells.

Authors:  S M Zawaneh; E M Ayoub; H Baer; A C Cruz; W N Spellacy
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

3.  The adherence of group A streptococci to oropharyngeal cells: the lipoteichoic acid adhesin and fibronectin receptor.

Authors:  E H Beachey; W A Simpson
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 4.  Group B streptococcal vaccines.

Authors:  C J Baker; D L Kasper
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

5.  Extraction and purification of lipoteichoic acids from Gram-positive bacteria.

Authors:  J Coley; M Duckworth; J Baddiley
Journal:  Carbohydr Res       Date:  1975-03       Impact factor: 2.104

6.  Erythrocyte binding properties of streptococcal lipoteichoic acids.

Authors:  E H Beachey; J B Dale; W A Simpson; J D Evans; K W Knox; I Ofek; A J Wicken
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Characteristics of the binding of streptococcal lipoteichoic acid to human oral epithelial cells.

Authors:  W A Simpson; I Ofek; C Sarasohn; J C Morrison; E H Beachey
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

8.  Soluble group- and type-specific antigens from type III group B Streptococcus.

Authors:  R B Carey; T K Eisenstein; G D Shockman; T F Greber; R M Swenson
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

9.  Cell membrane-binding properties of group A streptococcal lipoteichoic acid.

Authors:  I Ofek; E H Beachey; W Jefferson; G L Campbell
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

10.  Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein.

Authors:  E H Beachey; I Ofek
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  16 in total

1.  Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products.

Authors:  M Cuzzola; G Mancuso; C Beninati; C Biondo; C von Hunolstein; G Orefici; T Espevik; T H Flo; G Teti
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 2.  Multiple adhesins of streptococci.

Authors:  D L Hasty; I Ofek; H S Courtney; R J Doyle
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 3.  Atypical lipoteichoic acids of gram-positive bacteria.

Authors:  I C Sutcliffe; N Shaw
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

4.  Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells.

Authors:  Miriam J Baron; Dennis L Kasper
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

5.  Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components.

Authors:  G S Tamura; J M Kuypers; S Smith; H Raff; C E Rubens
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells.

Authors:  Axel Schubert; Katherina Zakikhany; Giampiero Pietrocola; Andreas Meinke; Pietro Speziale; Bernhard J Eikmanns; Dieter J Reinscheid
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032).

Authors:  P Canepari; M Boaretti; M M Lleó; G Satta
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  Sialic acid content and surface hydrophobicity of group B streptococci.

Authors:  L A Teixeira; A M Figueiredo; B T Ferreira; V M Alves; P E Nagao; C S Alviano; J Angluster; F C Silva-Filho; L C Benchetrit
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

9.  Group B streptococcus induces trophoblast death.

Authors:  Amber Kaplan; Kathy Chung; Hande Kocak; Cristina Bertolotto; Andy Uh; Calvin J Hobel; Charles F Simmons; Kelly Doran; George Y Liu; Ozlem Equils
Journal:  Microb Pathog       Date:  2008-07-02       Impact factor: 3.738

10.  Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.

Authors:  G Teti; G Mancuso; F Tomasello
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.